Catheter Precision, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Catheter Precision, Inc. (VTAK) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $266.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-14
- Catheter Precision, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $266.00K, a 171.43% increase year-over-year.
- Catheter Precision, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $64.00K, a 29.67% decline year-over-year.
- Catheter Precision, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $70.00K, a 311.76% increase year-over-year.
- Catheter Precision, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $98.00K, a 653.85% increase year-over-year.
- Catheter Precision, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $338.00K, a 525.93% increase from fiscal 2024.
- Catheter Precision, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $54.00K, a 95.56% decline from fiscal 2023.
- Catheter Precision, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.22M, a 172.26% increase from fiscal 2022.
- Catheter Precision, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $447.00K, a 80.02% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $266.00K 10-Q · filed 2026-08-14 | $330.00K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $64.00K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $338.00K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $70.00K 10-Q · filed 2025-11-13 | $168.00K derived: sum of 2 quarters · filed 2026-08-14 | $259.00K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-06-30 | $98.00K 10-Q · filed 2026-08-14 | $189.00K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $91.00K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $54.00K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $17.00K 10-Q · filed 2025-11-13 | $30.00K derived: sum of 2 quarters · filed 2025-11-13 | $36.00K derived: sum of 3 quarters · filed 2025-11-13 | |
| 2024-06-30 | $13.00K 10-Q · filed 2025-11-13 | $19.00K derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-03-31 | $6.00K 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $1.22M 10-K · filed 2025-03-31 | |||
| 2022-12-31 | $82.00K derived: 10-K 12 month − 3 quarters · filed 2023-03-28 | $156.00K derived: sum of 2 quarters · filed 2023-03-28 | $282.00K derived: sum of 3 quarters · filed 2023-03-28 | $447.00K 10-K · filed 2023-03-28 |
| 2022-09-30 | $74.00K 10-Q · filed 2022-11-14 | $200.00K derived: sum of 2 quarters · filed 2022-11-14 | $365.00K derived: sum of 3 quarters · filed 2022-11-14 | |
| 2022-06-30 | $126.00K 10-Q · filed 2022-11-14 | $291.00K derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2022-03-31 | $165.00K 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | $2.24M 10-K · filed 2023-03-28 | |||
| 2021-09-30 | $102.00K 10-Q · filed 2022-11-14 | $798.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.97M derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-06-30 | $696.00K 10-Q · filed 2022-11-14 | $1.86M derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2021-03-31 | $1.17M 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $4.08M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $964.00K 10-Q · filed 2021-11-15 | $2.00M derived: sum of 2 quarters · filed 2021-11-15 | $3.04M derived: sum of 3 quarters · filed 2021-11-15 | |
| 2020-06-30 | $1.03M 10-Q · filed 2021-11-15 | $2.08M derived: sum of 2 quarters · filed 2021-11-15 | ||
| 2020-03-31 | $1.05M 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $23.54M 10-K · filed 2021-03-17 | |||
| 2019-09-30 | $7.28M 10-Q · filed 2020-11-16 | $14.41M derived: sum of 2 quarters · filed 2020-11-16 | $22.15M derived: sum of 3 quarters · filed 2020-11-16 | $29.97M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $7.13M 10-Q · filed 2020-11-16 | $14.88M derived: sum of 2 quarters · filed 2020-11-16 | $22.69M derived: sum of 3 quarters · filed 2020-11-16 | $24.20M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-03-31 | $7.75M 10-Q · filed 2020-11-16 | $15.56M derived: sum of 2 quarters · filed 2020-11-16 | $17.07M derived: sum of 3 quarters · filed 2020-11-16 | $18.09M derived: sum of 4 quarters · filed 2020-11-16 |
| 2018-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $9.32M derived: sum of 2 quarters · filed 2020-03-11 | $10.35M derived: sum of 3 quarters · filed 2020-03-11 | $10.35M 10-K · filed 2020-03-11 |
| 2018-09-30 | $1.51M 10-Q · filed 2019-11-29 | $2.53M derived: sum of 2 quarters · filed 2019-11-29 | $2.53M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.02M 10-Q · filed 2019-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |